Obesity
|
0.040 |
Biomarker
|
disease |
BEFREE |
(2013) now extend this link, demonstrating that deletion of the telomere binding protein RAP1 leads to obesity and insulin resistance.
|
23809762 |
2013 |
Malignant neoplasm of stomach
|
0.020 |
Biomarker
|
disease |
BEFREE |
24 SNPs in eight genes (ERK, Dock180, C3G, Rap1, Src, CrkL, Mek and Crk) were significantly associated with gastric cancer risk in the individual SNP analyses in the discovery phase (p<0.05).
|
21698158 |
2011 |
Stomach Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
24 SNPs in eight genes (ERK, Dock180, C3G, Rap1, Src, CrkL, Mek and Crk) were significantly associated with gastric cancer risk in the individual SNP analyses in the discovery phase (p<0.05).
|
21698158 |
2011 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Rap1-suppressed tumorigenesis is concomitant with the interference in ras effector signaling.
|
10675535 |
2000 |
Astrocytoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Rap1 activity is elevated in malignant astrocytomas independent of tuberous sclerosis complex-2 gene expression.
|
12469204 |
2003 |
Tuberous Sclerosis
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Rap1 activity is elevated in malignant astrocytomas independent of tuberous sclerosis complex-2 gene expression.
|
12469204 |
2003 |
Squamous cell carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Rap1 is variably expressed in whole cell lysates of squamous cell carcinoma (SCC) cell lines.
|
13679863 |
2003 |
Hematologic Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Rap1 and its regulator, SPA-1, could, therefore, provide unique molecular targets for the control of human hematologic malignancy.
|
15310461 |
2004 |
Tumor Progression
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
RAP1 expression may be a useful biomarker of tumor progression and survival.
|
17020976 |
2006 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
RAP1 was shown to have both mitogenic and tumorigenic properties in certain systems; however, the potential role of RAP1 mutation in thyroid carcinogenesis has yet to be elucidated.
|
18948674 |
2009 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Rap1 stabilizes beta-catenin and enhances beta-catenin-dependent transcription and invasion in squamous cell carcinoma of the head and neck.
|
20028760 |
2010 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Rap1, a small GTPase protein, has been implicated in cancer cell growth and invasion.
|
22266190 |
2012 |
Impaired glucose tolerance
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Rap1 inhibition causes dysregulation in hepatic as well as adipose function, leading to glucose intolerance, insulin resistance, liver steatosis, and excess fat accumulation.
|
23791522 |
2013 |
Secondary Neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
RABEX-5, a guanine nucleotide exchange factor (GEF) for RAB-5, plays an important role in cell mobility and altered expression associated with tumor metastasis.
|
23941575 |
2013 |
Malignant neoplasm of breast
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
RABEX-5 expression was examined in breast cancer, benign tumor and normal breast tissues by immunohistochemistry and western blot.
|
23941575 |
2013 |
Breast Carcinoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
RABEX-5 expression was examined in breast cancer, benign tumor and normal breast tissues by immunohistochemistry and western blot.
|
23941575 |
2013 |
Benign Neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
RABEX-5 expression was found to be significantly higher in breast cancer tissues compared with benign tumor and normal breast tissues.
|
23941575 |
2013 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
RABEX-5, a guanine-nucleotide exchange factor (GEF) for RAB-5, is implicated in tumorigenesis and in the development of certain human cancers.
|
25427001 |
2014 |
Endothelial dysfunction
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Rap1 deficiency in murine endothelium attenuates NO production and diminishes NO-dependent vasodilation, leading to endothelial dysfunction and hypertension, without deleterious effects on vessel integrity.
|
25807985 |
2015 |
Hypertensive disease
|
0.010 |
Biomarker
|
group |
BEFREE |
Rap1 deficiency in murine endothelium attenuates NO production and diminishes NO-dependent vasodilation, leading to endothelial dysfunction and hypertension, without deleterious effects on vessel integrity.
|
25807985 |
2015 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
RAP1 (RAS proximate 1), a small GTP-binding protein of the RAS superfamily, is a putative oncogene that is highly expressed in several malignant cell lines and types of cancers, including some types of squamous cell carcinoma.
|
25856570 |
2015 |
Squamous cell carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
RAP1 (RAS proximate 1), a small GTP-binding protein of the RAS superfamily, is a putative oncogene that is highly expressed in several malignant cell lines and types of cancers, including some types of squamous cell carcinoma.
|
25856570 |
2015 |
Solid Neoplasm
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
RABEX-5 has been studied in various solid tumors, but its role in combined small cell lung cancer (C-SCLC) remains unknown.
|
26002576 |
2015 |
Kabuki make-up syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome.
|
26280580 |
2015 |
Colorectal Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
RABEX-5 mRNA expression was significantly upregulated in CRC tissues compared with the adjacent noncancerous tissues (p < 0.01).
|
28617553 |
2017 |